Fabiana Lubieniecki
Overview
Explore the profile of Fabiana Lubieniecki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foncuberta M, Monges S, Medina A, Lubieniecki F, Gravina L
Gene
. 2024 Aug;
930:148862.
PMID: 39151676
Dystrophinopathies are a group of neuromuscular disorders, inherited in an X-linked recessive manner, caused by pathogenic variants in the DMD gene. Copy number variation detection and next generation sequencing allow...
2.
Zugbi S, Aschero R, Ganiewich D, Cancela M, Winter U, Ottaviani D, et al.
Invest Ophthalmol Vis Sci
. 2023 Dec;
64(15):27.
PMID: 38117242
Purpose: Although there have been improvements in the management of metastatic retinoblastoma, most patients do not survive, and all patients suffer from multiple short- and long-term treatment toxicities. Reliable and...
3.
Aschero R, Ganiewich D, Lamas G, Restrepo-Perdomo C, Ottaviani D, Zugbi S, et al.
Pediatr Blood Cancer
. 2023 Oct;
71(1):e30717.
PMID: 37814421
Introduction: The risk of relapse in retinoblastoma is currently determined by the presence of high-risk histopathologic factors in the enucleated eye. However, the probability of developing metastatic disease is heterogeneous...
4.
Gomez-Gonzalez S, Llano J, Garcia M, Garrido-Garcia A, Sunol M, Lemos I, et al.
iScience
. 2023 Sep;
26(9):107598.
PMID: 37664618
Molecular classification of medulloblastoma is critical for the treatment of this brain tumor. Array-based DNA methylation profiling has emerged as a powerful approach for brain tumor classification. However, this technology...
5.
Baroni L, Fernandez Ponce N, Freytes C, Maldonado F, Pinto N, Gonzalez Ramos J, et al.
Front Oncol
. 2023 Jun;
13:1185766.
PMID: 37274284
No abstract available.
6.
Lubieniecki F, Vazquez V, Lamas G, Camarero S, Nunez F, Baroni L, et al.
Childs Nerv Syst
. 2022 Dec;
39(2):379-386.
PMID: 36534132
Purpose: Central nervous system high-grade neuroepithelial tumor with MN1 alteration (CNS-HGNET-MN1) is a rare entity defined by its DNA methylation pattern and pathologically considered to be high-grade with mixed patterns,...
7.
Labasse C, Brochier G, Taratuto A, Cadot B, Rendu J, Monges S, et al.
Acta Neuropathol Commun
. 2022 Jul;
10(1):101.
PMID: 35810298
Nemaline myopathy (NM) is a muscle disorder with broad clinical and genetic heterogeneity. The clinical presentation of affected individuals ranges from severe perinatal muscle weakness to milder childhood-onset forms, and...
8.
Baroni L, Cassina T, Fernandez Ponce N, Pinto N, Vazquez V, Lubieniecki F, et al.
J Pediatr Hematol Oncol
. 2022 Jun;
44(7):415-418.
PMID: 35704799
Medulloblastoma has a reduced incidence in Down syndrome (DS). This protective characteristic has not been clarified yet. Here, we report the second case of SHH medulloblastoma and DS documented in...
9.
Cuadrado-Vilanova M, Liu J, Paco S, Aschero R, Burgueno V, Sirab N, et al.
J Pathol
. 2022 Mar;
257(3):327-339.
PMID: 35254670
The microenvironment of retinoblastoma, the solid malignancy of the developing retina, is immunosuppressive. To study the interactions between tumor-associated microglia/macrophages (TAMs) and tumor cells in retinoblastomas, we analyzed immunohistochemistry markers...
10.
Warriner E, Fernandez Ponce N, Freytes C, Sampor C, Oller A, Rugilo C, et al.
Medicina (B Aires)
. 2021 Oct;
81(5):791-799.
PMID: 34633954
The BRAFV600E point mutation plays a key role in the tumorigenesis of many gliomas. Inhibiting its product is part of the innovative therapies emerging in recent years. Knowing the role...